Affitech AS Strengthens Management As Lead Oncology Antibodies Enter Development Phase

OSLO, Norway--(BUSINESS WIRE)--Affitech today announced at BIO-Europe that it is strengthening its management team with the recruitment of Hans Petter Tjeldflaat as the new Director of Finance, and the assignment of Dr Rathin Das as the Senior Vice President of Corporate Development and CBO. The two appointments follow Affitech’s successful funding round in the spring of 2006, which has enabled the company to move its portfolio of therapeutic oncology antibodies beyond the discovery into the pre-clinical development phase.